Exploratory Early Phase Clinical Development

Exploratory/Early Phase Clinical Development (from First-in-Man to Proof-of-Principle and/or Proof-of-Concept)

• As your partner in early clinical drug development, the Aepodia team will work in close collaboration with you to develop an optimal early phase clinical research strategy and plan.
• All relevant pharmaceutical, pharmacological, efficacy, toxicology and metabolism information (preclinical and clinical) is evaluated to establish clinical development plan to support a Go/No Go decision as quickly and as efficiently as possible.
• Studies are designed to address primary key objectives and help the compound move forward to the next critical decision point.

Aepodia has therapeutic area expertise in:

• Central Nervous System (pain, Alzheimer, depression, sleep, Parkinson, ...);
• Metabolic disease (obesity);
• Endocrine (diabetes);
• Cardiovascular (hypertension, coagulation, QTc studies,...);
• Inflammatory diseases (rheumatoid arthritis, osteo arthritis);
• Urology, Impotency;
• Respiratory (asthma, COPD)